RSS-Feed abonnieren
DOI: 10.1055/s-0044-1788619
Clinicohematological Profile of Patients with Bicytopenia
Abstract
Background Bicytopenia (BC) is a reduction in counts in any of two cell lineages of blood, which can be a combination of anemia with thrombocytopenia, anemia with leukopenia, or leukopenia with thrombocytopenia. The etiology of BC can be a malignancy, nonmalignant disease, infectious cause, or drug-induced.
Aim To assess the clinicohematological profile in patients with BC.
Materials and Methods This prospective study was conducted in the hematology laboratory at the Justice K.S. Hegde Charitable Hospital. Patients with BC detected during the analysis of blood for any clinical condition were included in the study. Blood parameters assessed were hemoglobin, red blood cell count, total leukocyte count, and platelet count.
Results In this study, 86 patients' samples with BC were collected, out of which 55.8% were male, and 44.2% were female. The most common BC was anemia with thrombocytopenia (69.8%). The most common etiology of BC was found to be nonmalignant (37.2%), followed by malignant (37.2%), infectious (25.6%), and drug-induced (4.7%) cases. Most of the patients with BC presented with fever, pallor, and generalized weakness.
Conclusion Anemia with thrombocytopenia emerged as the predominant form of BC in the nonmalignant group, while the malignant etiology group presented with anemia with leukopenia. The infectious etiology group presented with leukopenia with thrombocytopenia. Neonatal sepsis emerged as the most prevalent cause of BC in the age group younger than 10 years, viral fever in the age group of 10 to 39 years, acute lymphoblastic leukemia in the age group of older than 70 years, and chronic liver disease in patients aged between 40 and 69 years.
Publikationsverlauf
Artikel online veröffentlicht:
23. Juli 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Alim M, Verma N, Kumar A, Pooniya V, Abdul Rahman R. Etio-hematological profile and clinical correlates of outcome of pancytopenia in children: experience from a tertiary care center in North India. Cureus 2021; 13 (06) e15382
- 2 Dagdia K, Deshmukh A, Soni R, Jane D. Haematological indices and bone marrow morphology in pancytopenia/bicytopenia. Egypt J Haematol 2016; 41 (01) 23-26
- 3 Singh A, Hungund B, Kumar L, Pattanshetti M. Clinico-haematological profile of patients with bicytopenia. Pathology 2018; 50 (05) 540-548
- 4 Thakur R, Kaur N, Arjun M, Sanjeevan S, Pankaj P, Velu N. Clinicohematological profile of patients with peripheral blood cytopenias in clinical practice. Iraqi J Hematol. 2019; 8 (01) 1-6
- 5 Naseem S, Varma N, Das R, Ahluwalia J, Sachdeva MU, Marwaha RK. Pediatric patients with bicytopenia/pancytopenia: review of etiologies and clinico-hematological profile at a tertiary center. Indian J Pathol Microbiol 2011; 54 (01) 75-80
- 6 Sarbay H. Comparison of the severity of cytopenias with etiologic factors in patients with pancytopenia and bicytopenia. Pan Afr Med J 2019; 34 (149) 149
- 7 Bates I, Bain B. Approach to diagnosis and classification of blood diseases. In: Lewis S, Bain B, Bates I. et al., eds. Dacie and Lewis Practical Haematology. 12th ed. Philadelphia: Churchill Livingstone; 2017: 549-562
- 8 Katoch P, Roach V, Singh S. Clinicohaematological profile in paediatric patients with bicytopenia and pancytopenia in a tertiary care referral centre of North India. J Adv Med Med Res 2021; 33 (18) 57-63
- 9 Kato H, Hamada Y, Hagihara M. et al. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy. J Infect Chemother 2015; 21 (10) 707-712
- 10 Vadhan-Raj S. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Semin Hematol 2009; 46 (1, suppl 2): S26-S32
- 11 Yang J, Yan B, Yang L. et al. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study. BMC Gastroenterol 2018; 18 (01) 161
- 12 Viana MB. Anemia and infection: a complex relationship. Rev Bras Hematol Hemoter 2011; 33 (02) 90-92
- 13 Swain MG. Fatigue in liver disease: pathophysiology and clinical management. Can J Gastroenterol 2006; 20 (03) 181-188
- 14 Stefanidakis M, Karjalainen K, Jaalouk DE. et al. Role of leukemia cell invadosome in extramedullary infiltration. Blood 2009; 114 (14) 3008-3017
- 15 Vijay Anand M, Logeshwaran K, Srenivas A, Sathiya Suresh R. Children with bicytopenia and pancytopenia-clinical picture, etiological spectrum and outcome. Asian J Med Sci 2024; 15 (06) 113-118
- 16 Ashraf SO, Hamid AM, Pal HS. Double deficiency anemia as a major cause of cytopenias in patients of chronic liver disease. Pak J Med Health Sci 2018; 12 (02) 707-709
- 17 Taal MW, Glenn MC, Marsden PA, Skorecki K, Yu ASL, Brenner BM. Brenner and Rector's The Kidney. 9th edition. Philadelphia, PA: elsevier/Saunders; 2011: 2962 p
- 18 Hoffbrand AV. Moss PAH.Hoffbrand's. Essential Haematology. Seventh Edition. Chichester. West Sussex; Hoboken, NJ: John Wiley & Sons; 2016: 1-369 p
- 19 Vayne C, Guéry EA, Rollin J, Baglo T, Petermann R, Gruel Y. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J Clin Med 2020; 9 (07) 1-19